Back to results
TerminatedPhase 2Phase 3

Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease

NCT04886063

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Rochester-AD-CARE Program

Rochester, New York, United States

View on ClinicalTrials.gov
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease — TrialFind